Company Filing History:
Years Active: 2018-2021
Title: Innovations by Cheng-Chia Yu in Biotechnology
Introduction
Cheng-Chia Yu is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of immunomodulatory proteins. With a total of 2 patents, his work focuses on innovative methods for treating serious health conditions.
Latest Patents
Cheng-Chia Yu's latest patents include groundbreaking inventions aimed at addressing critical health issues. One of his patents is titled "Use of immunomodulatory protein from in inhibiting fibrosis." This invention provides a method for preventing or treating fibrosis in a subject by administering an effective amount of an immunomodulatory protein derived from specific sources. Another significant patent is "Use of immunomodulatory protein from ganoderma in inhibiting cancer stem cells." This invention relates to a new application of an immunomodulatory protein in inhibiting cancer stem cells, particularly targeting oral cancer stem cells.
Career Highlights
Cheng-Chia Yu is currently associated with Mycomagic Biotechnology Co., Ltd. His work at this company emphasizes the importance of research and development in the biotechnology sector. His innovative approaches have the potential to lead to significant advancements in medical treatments.
Collaborations
Due to space constraints, the details regarding collaborations will not be included.
Conclusion
Cheng-Chia Yu's contributions to biotechnology through his patents demonstrate his commitment to advancing medical science. His innovative work in immunomodulatory proteins holds promise for future treatments of fibrosis and cancer.